Abstract
No public abstract is available from the verified source records.
Song'’en Dai
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Global, regional, and national burdens of colorectal cancer and inflammatory bowel disease, 1990–2021 and projections to 2050: a cross-sectional study
10.1097/js9.0000000000004428 · 2026
The global burden of inflammatory bowel disease: from 2025 to 2045
10.1038/s41575-025-01097-1 · 2025
Colorectal cancer in inflammatory bowel diseases: epidemiology and prevention: a review
10.3390/cancers14174254 · 2022
Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments
10.1016/j.tips.2024.08.003 · 2024
The current consensus on ulcerative colitis, and the evidence and perspectives on the influence of gut microbiota on it
2026
Colorectal cancer risk in ulcerative colitis: an updated population-based systematic review and meta-analysis
10.1016/j.eclinm.2025.103269 · 2025
Stable incidence and risk factors of colorectal cancer in ulcerative colitis: a population-based cohort between 1977–2020
10.1016/j.cgh.2023.03.022 · 2024
Mechanisms and implications of the gut microbial modulation of intestinal metabolic processes
10.1038/s44324-025-00066-1 · 2025
β-Glucuronidase at the microbiota—host interface: dual regulatory roles and precision modulation by natural products
10.3390/molecules31040601 · 2026
β-Glucuronidases of opportunistic bacteria are the major contributors to xenobiotic-induced toxicity in the gut
10.1038/s41598-018-34678-z · 2018
Fusobacterium nucleatum in health and disease
10.1002/mco2.70465 · 2025
Gut microbial β-glucuronidases and their role in the microbiome-metabolite axis in colorectal cancer
2025
Intestinal bacterial β-glucuronidase activity of patients with colon cancer
10.1007/bf02975166 · 2001
Advances in non-invasive screening methods for gastrointestinal cancers: how continued innovation has revolutionized early cancer detection
10.3390/cancers17071085 · 2025
Current and future colorectal cancer screening strategies
10.1038/s41575-022-00612-y · 2022
Current status and emerging trends in colorectal cancer screening and diagnostics
10.3390/bios13100926 · 2023
Advances in fecal occult blood tests: the FIT revolution
10.1007/s10620-014-3445-3 · 2015
New faecal tests in gastroenterology
10.1258/acb.2011.011150 · 2012
Recent progress on affibody-based supramolecular architectures: moving from monomeric constructs to multivalent assemblies
10.3390/ph18111669 · 2025
Engineering of affibody molecules
2024
Alternative binding proteins: affibody binding proteins developed from a small three-helix bundle scaffold
10.1111/j.1742-4658.2008.06438.x · 2008
Affibody molecules in biotechnological and medical applications
10.1016/j.tibtech.2017.04.007 · 2017
Integrating molecular docking and molecular dynamics simulations
2019
Discovery of a broad-spectrum affibody ligand for COVID-19 vaccine purification
2025
Novel affibody molecules specifically bind to SARS-CoV-2 spike protein and efficiently neutralize delta and omicron variants
10.1128/spectrum.03562-22 · 2023
A simplified and miniaturized glucometer-based assay for the detection of β-glucosidase activity
10.1631/jzus.b1800416 · 2019
Accurate structure prediction of biomolecular interactions with AlphaFold 3
10.1038/s41586-024-07487-w · 2024
A comprehensive benchmarking of the AlphaFold3 for predicting biomacromolecules and their interactions
10.1093/bib/bbaf616 · 2025
DDMut-PPI: predicting effects of mutations on protein–protein interactions using graph-based deep learning
10.1093/nar/gkae412 · 2024
Unresolved referenced work
2026
Heterogeneous parallelization and acceleration of molecular dynamics simulations in GROMACS
10.1063/5.0018516 · 2020
Expression and purification of soluble His6-tagged TEV protease
2009
Applications of circular dichroism (CD) for structural analysis of proteins: qualification of near-and far-UV CD for protein higher order structural analysis
10.1002/jps.22695 · 2011
Studying molecular interactions via capillary electrophoresis and microscale thermophoresis: a review
10.1002/elps.202200275 · 2023
Structural stability of Calmodulin-target peptide complex at different temperatures based on molecular dynamics simulation
10.1186/s13065-025-01515-0 · 2025
Abnormal SDS-PAGE migration of cytosolic proteins can identify domains and mechanisms that control surfactant binding
10.1002/pro.2107 · 2012
The regulation of host cellular and gut microbial metabolism in the development and prevention of colorectal cancer
10.1080/1040841x.2018.1425671 · 2018
The struggle within: microbial influences on colorectal cancer
10.1002/ibd.21354 · 2011
Microbiota-associated metabolites and related immunoregulation in colorectal cancer
10.3390/cancers13164054 · 2021
The role of gut microbial β-glucuronidases in carcinogenesis and cancer treatment: a scoping review
10.1007/s00432-024-06028-2 · 2024
Adding a twist to lateral flow immunoassays: a direct replacement of antibodies with helical affibodies, from selection to application
10.1021/jacs.4c17452 · doi-reference
Unraveling the hook effect: a comprehensive study of high antigen concentration effects in sandwich lateral flow immunoassays
10.1021/acs.analchem.0c03740 · doi-reference
Ultrasensitive and highly specific lateral flow assays for point-of-care diagnosis
10.1021/acsnano.0c10035 · doi-reference
Beyond traditional lateral flow assays: enhancing performance through multianalytical strategies
10.3390/bios15020068 · doi-reference
New technologies and reagents in lateral flow assay (LFA) designs for enhancing accuracy and sensitivity
10.1039/d3ay00844d · doi-reference
Advancements and applications of lateral flow assays (LFAs): a comprehensive review
10.3390/s25175414 · doi-reference
Recent advances of affibody molecules in biomedical applications
10.1016/j.bmc.2024.117923 · doi-reference
Impact of host and environmental factors on β-glucuronidase enzymatic activity: implications for gastrointestinal serotonin
10.1152/ajpgi.00026.2020 · doi-reference
Targeting gut microbiota-derived β-glucuronidase to reduce enterotoxicity: research progress on strategies and prospects for the application of food and medicine homology
10.26599/fmh.2026.9420139 · doi-reference
Designs, formats and applications of lateral flow assay: a literature review
10.1016/j.jscs.2014.09.001 · doi-reference